Haemonetics 2nd Quarter and 1st Half Fiscal 2018 Earnings Release Available on Investor Relations Website

Go back to Haemonetics 2nd Quarter and 1st Half Fiscal 2018 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) PT Raised to $59 at Jefferies; Reiterates Buy

November 8, 2017 9:08 AM EST

Jefferies raised its price target on Haemonetics (NYSE: HAE) to $59.00 (from $48.00) while maintaining a Buy rating. The upgrade cycle for NexSys appears underway with several customers launching trials in September while full market release mid-next year assumes new contracts are in place.

The... More